Patrick Mckiernan

NPI: 1346693116
Total Payments
$44,288
2023 Payments
$16,166
Companies
5
Transactions
39

Payment Breakdown by Category

Travel$22,707 (51.3%)
Consulting$20,587 (46.5%)
Food & Beverage$632.67 (1.4%)
Education$361.14 (0.8%)

Payments by Nature

Nature of Payment Amount Transactions Share
Travel and Lodging $22,707 12 51.3%
Consulting Fee $20,587 8 46.5%
Food and Beverage $632.67 9 1.4%
Education $361.14 10 0.8%

Top Paying Companies

Company Total Records Latest Year
SWEDISH ORPHAN BIOVITRUM AB $18,167 6 $0 (2020)
ALBIREO PHARMA, INC. $16,166 6 $0 (2023)
Intercept Pharmaceuticals, Inc. $5,060 3 $0 (2021)
Alexion Pharmaceuticals, Inc. $4,543 16 $0 (2018)
Retrophin, Inc. $351.68 8 $0 (2018)

Payment History by Year

Year Amount Transactions Top Company
2023 $16,166 6 ALBIREO PHARMA, INC. ($16,166)
2021 $5,060 3 Intercept Pharmaceuticals, Inc. ($5,060)
2020 $5,000 1 SWEDISH ORPHAN BIOVITRUM AB ($5,000)
2018 $461.98 10 Retrophin, Inc. ($351.68)
2017 $17,600 19 Swedish Orphan Biovitrum AB ($13,167)

All Payment Transactions

39 individual payment records from CMS Open Payments — Page 1 of 2

Date Company Product Nature Form Amount Type
06/05/2023 ALBIREO PHARMA, INC. Bylvay (Drug) Consulting Fee Cash or cash equivalent $4,040.51 General
Category: Gastroenterology
03/21/2023 ALBIREO PHARMA, INC. Bylvay (Drug) Travel and Lodging In-kind items and services $2,630.00 General
Category: Gastroenterology
03/21/2023 ALBIREO PHARMA, INC. Bylvay (Drug) Travel and Lodging In-kind items and services $37.47 General
Category: Gastroenterology
01/19/2023 ALBIREO PHARMA, INC. Bylvay (Drug) Travel and Lodging In-kind items and services $7,249.57 General
Category: Gastroenterology
01/19/2023 ALBIREO PHARMA, INC. Bylvay (Drug) Travel and Lodging In-kind items and services $1,222.20 General
Category: Gastroenterology
01/18/2023 ALBIREO PHARMA, INC. Bylvay (Drug) Consulting Fee Cash or cash equivalent $986.25 General
Category: Gastroenterology
03/02/2021 Intercept Pharmaceuticals, Inc. Consulting Fee Cash or cash equivalent $1,480.00 General
03/02/2021 Intercept Pharmaceuticals, Inc. Consulting Fee Cash or cash equivalent $60.00 General
01/20/2021 Intercept Pharmaceuticals, Inc. Consulting Fee Cash or cash equivalent $3,520.00 General
02/13/2020 SWEDISH ORPHAN BIOVITRUM AB ORFADIN (Drug) Consulting Fee Cash or cash equivalent $5,000.00 General
Category: GENETICS AND METABOLISM
11/01/2018 Alexion Pharmaceuticals, Inc. Kanuma (Drug) Education In-kind items and services $8.30 General
Category: Immunology
09/14/2018 Alexion Pharmaceuticals, Inc. Kanuma (Drug) Food and Beverage In-kind items and services $102.00 General
Category: Immunology
07/12/2018 Retrophin, Inc. (820) Cholbam (Drug) Education In-kind items and services $43.96 General
Category: Hepatology
07/12/2018 Retrophin, Inc. (820) Cholbam (Drug) Education In-kind items and services $43.96 General
Category: Hepatology
07/12/2018 Retrophin, Inc. (820) Cholbam (Drug) Education In-kind items and services $43.96 General
Category: Hepatology
07/12/2018 Retrophin, Inc. (820) Cholbam (Drug) Education In-kind items and services $43.96 General
Category: Hepatology
07/12/2018 Retrophin, Inc. (820) Cholbam (Drug) Education In-kind items and services $43.96 General
Category: Hepatology
07/12/2018 Retrophin, Inc. (820) Cholbam (Drug) Education In-kind items and services $43.96 General
Category: Hepatology
07/12/2018 Retrophin, Inc. (820) Cholbam (Drug) Education In-kind items and services $43.96 General
Category: Hepatology
07/12/2018 Retrophin, Inc. (820) Cholbam (Drug) Education In-kind items and services $43.96 General
Category: Hepatology
12/20/2017 Alexion Pharmaceuticals, Inc. Kanuma (Drug) Food and Beverage In-kind items and services $118.75 General
Category: Immunology
11/30/2017 Swedish Orphan Biovitrum AB Orfadin (Drug) Travel and Lodging Cash or cash equivalent $9,467.21 General
Category: Genetics and metabolism
11/30/2017 Swedish Orphan Biovitrum AB Orfadin (Drug) Consulting Fee Cash or cash equivalent $3,000.00 General
Category: Genetics and metabolism
11/30/2017 Swedish Orphan Biovitrum AB Orfadin (Drug) Travel and Lodging Cash or cash equivalent $315.90 General
Category: Genetics and metabolism
11/30/2017 Swedish Orphan Biovitrum AB Orfadin (Drug) Travel and Lodging Cash or cash equivalent $259.49 General
Category: Genetics and metabolism

About Patrick Mckiernan

Patrick Mckiernan is a Pediatric Gastroenterology healthcare provider based in Pittsburgh, Pennsylvania. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/18/2016. The National Provider Identifier (NPI) number assigned to this provider is 1346693116.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Patrick Mckiernan has received a total of $44,288 in payments from pharmaceutical and medical device companies, with $16,166 received in 2023. These payments were reported across 39 transactions from 5 companies. The most common payment nature is "Travel and Lodging" ($22,707).

Practice Information

  • Specialty Pediatric Gastroenterology
  • Location Pittsburgh, PA
  • Active Since 07/18/2016
  • Last Updated 05/24/2021
  • Taxonomy Code 2080P0206X
  • Entity Type Individual
  • NPI Number 1346693116

Products in Payments

  • Bylvay (Drug) $16,166
  • Orfadin (Drug) $13,167
  • ORFADIN (Drug) $5,000
  • Kanuma (Drug) $4,418
  • (820) Cholbam (Drug) $351.68
  • Strensiq (Drug) $125.00

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Pediatric Gastroenterology Doctors in Pittsburgh